Sara Konstantin Nissen1, Kalpana Shrivastava1, Claudia Schulte2, Daniel Erik Otzen3, David Goldeck4, Daniela Berg5, Holger Jon Møller6, Walter Maetzler5, Marina Romero-Ramos1. 1. DANDRITE & Department of Biomedicine, Aarhus University, Aarhus, Denmark. 2. Hertie Institute for Clinical Brain Research, Department of Neurodegeneration, University of Tuebingen & German Center for Neurodegenerative Diseases, Tuebingen, Germany. 3. Department of Molecular Biology and Genetics & iNANO, Aarhus University, Aarhus, Denmark. 4. Department of Internal Medicine II, Centre for Medical Research, University of Tuebingen, Tuebingen, Germany. 5. Department of Neurology, Christian-Albrechts University, Kiel, Germany. 6. Department of Clinical Biochemistry, Aarhus University Hospital, Aarhus, Denmark.
Abstract
BACKGROUND: PD is a multisystem disease where both central and peripheral nervous systems are affected. This systemic involvement also includes the immune response in PD, which implicates not only microglia in the brain, but also peripheral immune cells, such as monocytes; however, this aspect has been understudied. OBJECTIVES: The purpose of this study was to investigate the PD-related changes in peripheral immune cells, their responsiveness to stimulation, and their ability to release immunomodulatory molecules that might have consequences for the disease progression. METHODS: Using flow cytometry, we investigated the monocytic population in peripheral blood mononuclear cells from PD patients and healthy individuals. We also evaluated the in vitro response to inflammogen lipopolysaccharides and to fibrillar α-synuclein by measuring the expression of CD14, CD163, and HLA-DR and by analysis of soluble immune-related molecules in the supernatant. RESULTS: Peripheral blood immune cells from PD patients had lower survival in culture, but showed a higher monocytic proliferative ability than control cells, which was correlated with shorter disease duration and late disease onset. In addition, PD patients' cells were less responsive to stimulation, as shown by the lack of changes in CD163 and CD14 expression, and by the absence of significant upregulation of anti-inflammatory cytokines in culture. Moreover, PD peripheral immune cells shed lower in vitro levels of soluble CD163, which suggests a less responsive monocytic population and/or an activation status different from control cells. Interestingly, some of the results were sex associated, supporting a differential immune response in females versus males. CONCLUSIONS: Our data suggest that PD involves monocytic changes in blood. These cells show reduced viability and are unresponsive to specific stimuli, which might have a relevant consequence for disease progression.
BACKGROUND:PD is a multisystem disease where both central and peripheral nervous systems are affected. This systemic involvement also includes the immune response in PD, which implicates not only microglia in the brain, but also peripheral immune cells, such as monocytes; however, this aspect has been understudied. OBJECTIVES: The purpose of this study was to investigate the PD-related changes in peripheral immune cells, their responsiveness to stimulation, and their ability to release immunomodulatory molecules that might have consequences for the disease progression. METHODS: Using flow cytometry, we investigated the monocytic population in peripheral blood mononuclear cells from PDpatients and healthy individuals. We also evaluated the in vitro response to inflammogen lipopolysaccharides and to fibrillar α-synuclein by measuring the expression of CD14, CD163, and HLA-DR and by analysis of soluble immune-related molecules in the supernatant. RESULTS: Peripheral blood immune cells from PDpatients had lower survival in culture, but showed a higher monocytic proliferative ability than control cells, which was correlated with shorter disease duration and late disease onset. In addition, PDpatients' cells were less responsive to stimulation, as shown by the lack of changes in CD163 and CD14 expression, and by the absence of significant upregulation of anti-inflammatory cytokines in culture. Moreover, PD peripheral immune cells shed lower in vitro levels of soluble CD163, which suggests a less responsive monocytic population and/or an activation status different from control cells. Interestingly, some of the results were sex associated, supporting a differential immune response in females versus males. CONCLUSIONS: Our data suggest that PD involves monocytic changes in blood. These cells show reduced viability and are unresponsive to specific stimuli, which might have a relevant consequence for disease progression.
Authors: Rebecca L Wallings; Laura P Hughes; Hannah A Staley; Zachary D Simon; Nikolaus R McFarland; Roy N Alcalay; Alicia Garrido; María José Martí; Eduardo Tolosa Sarró; Nicolas Dzamko; Malú Gámez Tansey Journal: Front Cell Neurosci Date: 2022-06-09 Impact factor: 6.147
Authors: Ruwani S Wijeyekoon; Deborah Kronenberg-Versteeg; Kirsten M Scott; Shaista Hayat; Wei-Li Kuan; Jonathan R Evans; David P Breen; Gemma Cummins; Joanne L Jones; Menna R Clatworthy; R Andres Floto; Roger A Barker; Caroline H Williams-Gray Journal: Brain Behav Immun Date: 2020-01-30 Impact factor: 19.227
Authors: Rachael H Earls; Kelly B Menees; Jaegwon Chung; James Barber; Claire-Anne Gutekunst; Manuel G Hazim; Jae-Kyung Lee Journal: J Neuroinflammation Date: 2019-12-03 Impact factor: 8.322